Literature DB >> 3723143

Alpha tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain.

M Halks-Miller, M Henderson, L F Eng.   

Abstract

This study explored the effects of the lipid-soluble free radical scavenger, alpha tocopherol (vitamin E), on neuronal injury and glial protein accumulation in a well-characterized, three-dimensional, mixed neuronal and glial culture system derived from fetal rat prosencephalon. As these reaggregated spheroidal cultures grew and enlarged, they developed small central areas of necrosis (presumably due to nutritional compromise) which we used as a model for central nervous system injury. Treatment with vitamin E (delivered in egg phosphatidylcholine liposomes beginning on day 8 in vitro) did not alter the appearance of the central necrotic areas, but it strongly suppressed the reaction of adjacent astroglia and microglia. Histological examination showed that by day 35 in vitro control cultures which received liposomes without tocopherol were nearly devoid of neurons and contained many glial and microglial cells. In contrast, tocopherol-treated cultures contained many viable-appearing neurons and did not exhibit an overgrowth of glia. Both glial fibrillary acidic protein (as measured by immunoassay) and lipid peroxidation (as estimated by malondialdehyde levels) were markedly reduced in the tocopherol-treated cultures. We speculate that the vitamin exerts its protective effect on injured nervous tissues by scavenging free radicals, stabilizing cellular membranes, and quenching the cascade of biochemical events that follows necrosis in brain. This work suggests that the signal(s) to initiate gliosis are mediated, at least indirectly, by free radical formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723143     DOI: 10.1097/00005072-198607000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Death of cerebellar granule neurons induced by piperine is distinct from that induced by low potassium medium.

Authors:  S Unchern; H Saito; N Nishiyama
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

Review 2.  Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.

Authors:  Przemyslaw Sapieha; Jean-Sebastien Joyal; José Carlos Rivera; Elsa Kermorvant-Duchemin; Florian Sennlaub; Pierre Hardy; Pierre Lachapelle; Sylvain Chemtob
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

3.  Vitamin E suppression of microglial activation is neuroprotective.

Authors:  Y Li; L Liu; S W Barger; R E Mrak; W S Griffin
Journal:  J Neurosci Res       Date:  2001-10-15       Impact factor: 4.164

4.  Antiproliferative effects of free and liposome-encapsulated retinoic acid in a squamous carcinoma model: monolayer cells and multicellular tumor spheroids.

Authors:  P G Sacks; V Oke; K Mehta
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Methylene blue is neuroprotective against mild traumatic brain injury.

Authors:  Lora Talley Watts; Justin Alexander Long; Jonathan Chemello; Samantha Van Koughnet; Angelica Fernandez; Shiliang Huang; Qiang Shen; Timothy Q Duong
Journal:  J Neurotrauma       Date:  2014-04-08       Impact factor: 5.269

6.  Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rb1 maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study.

Authors:  M M Herman; E Perentes; C D Katsetos; F Darcel; A Frankfurter; V P Collins; L A Donoso; L F Eng; P J Marangos; A F Wiechmann
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

Review 7.  Vitreous mediators in retinal hypoxic diseases.

Authors:  Roberto dell'Omo; Francesco Semeraro; Giulio Bamonte; Francesco Cifariello; Mario R Romano; Ciro Costagliola
Journal:  Mediators Inflamm       Date:  2013-01-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.